Intramesenteric steroid treatment for steroid-refractory gastrointestinal graft versus host disease

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Currently, steroid-refractory severe gastrointestinal (GI) graft versus host disease (GVHD) is among the most important complications of allogeneic transplantation, and as yet there is no standard approach to its treatment. Herein we report two cases with steroid-refractory GI GVHD that received intramesenteric steroid treatment. In both cases the frequency and volume of diarrhea resolved completely following intramesenteric methylprednisolone (MP) injection. In conclusion, intra-arterial steroid injection might be an alternative treatment approach for steroid-refractory GI GVHD.

Cite

CITATION STYLE

APA

Bilgin, A. U., Topcuoǧlu, P., Sancak, T., Konuk, N., & Arat, M. (2012). Intramesenteric steroid treatment for steroid-refractory gastrointestinal graft versus host disease. Turkish Journal of Hematology, 29(4), 409–412. https://doi.org/10.5505/tjh.2012.57855

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free